Nagendran Sukumar
- SEC CIK
- 0001665124
In the past year, 5 open-market sale filings worth $5.33M and no purchases.
Current role at each company
- TSHA Taysha Gene Therapies, Inc.President and Head of R&Das of Jul 10, 2026
- SLDB Solid Biosciences Inc.Directoras of Jun 11, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $5.33M
- 5 filings
- Net
- −$5.33M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Nagendran Sukumar as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TSHA Taysha Gene Therapies, Inc.
President and Head of R&D9 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2026 (view filing)6:54 PM ET | Jul 10 | Same day | Nagendran SukumarPresident and Head of R&D | SSale | −200.0K | $6.24 | −$1.25M | −17.6%936.4K after | 10b5-1 |
| Apr 13, 2026 (view filing) | Apr 10 | 3 days | Nagendran SukumarPresident and Head of R&D | SSale | −200.0K | $4.46 | −$892.0K | −15.0%1.14M after | 10b5-1 |
| Jan 27, 2026 (view filing) | Jan 23-26 | 4 days | Nagendran SukumarPresident and Head of R&D | SSale | −116.0K | $4.72 | −$547.5K | −8.1%1.32M after | 2 lots |
| Jan 14, 2026 (view filing) | Jan 12 | 2 days | Nagendran SukumarPresident and Head of R&D | SSale | −200.0K | $4.71 | −$942.0K | −16.6%1.01M after | 10b5-1 |
| Dec 1, 2025 (view filing) | Nov 28-Dec 1 | 3 days | Nagendran SukumarPresident and Head of R&D | SSale | −370.2K | $4.58 | −$1.70M | −26.9%1.01M after | 2 lots |
| Sep 12, 2025 (view filing) | Sep 10 | 2 days | Nagendran SukumarPresident and Head of R&D | SSale | −200.0K | $3.23 | −$646.0K | −16.6%1.01M after | 10b5-1 |
| Aug 22, 2025 (view filing) | Aug 21 | 1 day | Nagendran SukumarPresident and Head of R&D | SSale | −57.1K | $2.85 | −$162.6K | −4.7%1.17M after | |
| May 18, 2023 (view filing) | May 16 | 2 days | Nagendran SukumarPresident and Head of R&D | PPurchase | +5.00K | $0.68 | +$3.40K | +17.1%34.2K after | |
| Feb 3, 2022 (view filing) | Feb 2 | 1 day | Nagendran SukumarDirector | PPurchase | +10.0K | $8.01 | +$80.1K | +52.0%29.2K after |